For every 1000 patients aged 65 to 75 years treated for 5 years with pravastatin, 225 cardiovascular hospitalizations would be prevented compared with prevention of 121 cardiovascular hospitalizations in 1000 younger patients (Lewis et al 1998).
Outcome measures were number of patients infected, number of deaths, cost (in US$) per case prevented, and cost per death prevented compared to baseline where no preventive measures were implemented, as well as incremental cost per death averted compared with the corresponding lower level of alert status.
Reductions in total PEP events, driven by reductions in MI and stroke, more than doubled the number of events prevented compared with examining only the first event.
Treatment with zofenopril yielded an ICER of 2125.45 Euros for any additional event prevented compared with ramipril.
This means that for every 14 patients treated with a cemented Interax tibial component, 1 revision for aseptic loosening is prevented compared to the uncoated component.
The incremental cost per active TB case prevented, compared with no screening, was ₤ 47,840 in TST, ₤ 39.712 in T-SPOT.TB, ₤ 42,051 in QFT.
Positive values of incremental cost effectiveness mean that under MC complications are prevented compared to VCD; a positive signal thus represents a more favorable outcome of MC compared to VCD.> -wrap-foot> incrementalental cost effectiveness ratio, prev.
Between 5,653 and 10,815 carcinoma cases (female and male) would not be prevented compared with base case boys and girls vaccination, depending on the level of coverage rate assumed (Table 5).
According to our findings, treatment with zofenopril costs between 2023 Euros (best case sensitivity analysis) and 3590 Euros (worst case analysis) to generate any additional event prevented compared with ramipril.
The overall impact of these differences in costs and effects is that despite their greater benefits, cost-effectiveness ratios are higher if interventions are delivered to the Indigenous population via ACCHSs compared to mainstream GP practices (in the case of the polypill example, $21,000 per DALY prevented compared to $13,000 per DALY prevented respectively).
